ID: h-ccefee49
Hypothesis
SIRT3 Mitochondrial Activation to Counter Hub-Specific Energetic Vulnerability
SIRT3 Mitochondrial Activation to Counter Hub-Specific Energetic Vulnerability.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 5 support✗ 5 oppose
🧪 Overview
SIRT3 Mitochondrial Activation to Counter Hub-Specific Energetic Vulnerability
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["SIRT3 Activation<br/>NAD+-Dependent Deacetylase"]
B["MnSOD Deacetylation<br/>ROS Scavenging Capacity"]
C["Mitochondrial Energetics<br/>Improvement"]
D["Hub-Specific Vulnerability<br/>Targeted Protection"]
E["Neuronal Viability<br/>Enhanced"]
F["SIRT3 Mimetics<br/>as Neuroprotective Strategy"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix5 supports5 contradicts
Supports
SIRT3 expression declines with aging and AD, leading to mitochondrial dysfunction
Supports
Hub neurons show elevated oxidative stress markers and mitochondrial DNA damage
Contradicts
Resveratrol (SIRT3 activator) failed in multiple AD clinical trials including PEARL
Contradicts
SIRT3 knockout mice do not develop AD-like pathology - insufficient to drive disease
Contradicts
SIRT3 expression shows complex patterns - not consistently declined in early AD
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SIRT3
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for SIRT3 Mitochondrial from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SIRT3 Mitochondrial.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↗
Rising
7d Momentum
▲ 1.7%
Volatility
Low
0.0120
Events (7d)
3
Price History
▲32.9%💾 Resource Usage
LLM Tokens
47,826
$0.1435
Total Cost
$0.1435
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF SIRT3 is pharmacologically activated (e.g., with SIRT3 agonist CP-473041) in primary cortical neurons during metabolic stress (20h glucose deprivation), THEN hub neurons identified by viral labelin | Hub neurons will maintain higher ΔΨm (25-40% improvement) relative to non-hub neurons following SIRT3 activation under metabolic stress | — no observation — | pending | 0.45 |
| IF SIRT3 is knocked down using CRISPR interference (sgSIRT3) specifically in hub neurons in vivo, THEN hub neurons in the mouse medial prefrontal cortex will show accelerated dysfunction under chronic | SIRT3 knockdown in hub neurons will cause 40-60% reduction in hub neuron survival and 25-35% reduction in hub-hub functional connectivity | — no observation — | pending | 0.38 |
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF SIRT3 is pharmacologically activated (e.g., with SIRT3 agonist CP-473041) in primary cortical neurons during metabolic stress (20h glucose deprivation), THEN hub neurons identified by viral labeling of high-degree nodes will exhibit preferential preservation of mitochondrial membrane potential (Δ
Predicted outcome: Hub neurons will maintain higher ΔΨm (25-40% improvement) relative to non-hub neurons following SIRT3 activation under metabolic stress
Falsification: No significant difference in ΔΨm preservation between hub and non-hub neurons (p>0.05) following SIRT3 activation, or hub neurons show equal or greater vulnerability compared to non-hub neurons
pendingconf 38%
IF SIRT3 is knocked down using CRISPR interference (sgSIRT3) specifically in hub neurons in vivo, THEN hub neurons in the mouse medial prefrontal cortex will show accelerated dysfunction under chronic energy demand as evidenced by reduced survival (40-60% decrease in hub neuron density) and impaired
Predicted outcome: SIRT3 knockdown in hub neurons will cause 40-60% reduction in hub neuron survival and 25-35% reduction in hub-hub functional connectivity
Falsification: No significant difference in neuronal survival or functional connectivity metrics between SIRT3 knockdown and control groups (p>0.05) in either hub or non-hub neuron populations
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.